INFOSYS LTD
Last Traded Price @ 1490
Support Range @ 1474 / 1460
Resistance Range @ 1497 / 1508
Infosys Limited shares are likely to rise in the coming days. The company has recently won big deals and has built a strong position in its digital transformation, artificial intelligence and cloud services sectors. The growing demand for tech services in the US and European markets is helping the company’s revenue growth.
BHARAT FORGE
Last Traded Price @ 1402
Support Range @ 1388 / 1374
Resistance Range @ 1414 / 1420
Bharat Forge shares are likely to rise in the coming days. Strong demand in the automobile and machinery sectors is helping the company increase its revenue. New orders for infrastructure and auto-industry are positive for profitability. Control over raw material costs and efficiency improvements can also support the stock. All these reasons can strengthen the share price.
ICICI BANK
Last Traded Price @ 1374
Support Range @ 1357 / 1344
Resistance Range @ 1380 / 1393
The prospects for ICICI Bank shares to rise in the coming days are positive. The bank’s profits are continuing to grow, asset quality is improving and there is strong demand in the retail loan segment. Also, signs of economic growth and stable interest rates are favorable for the banking sector. Considering all these factors, ICICI Bank shares are likely to rise in the medium to long term.
AXIS BANK
Last Traded Price @ 1266
Support Range @ 1233 / 1217
Resistance Range @ 1278 / 1285
Axis Bank shares are likely to rise in the coming days. The bank’s latest quarterly results have shown strong profit, stable net interest margin and improvement in asset quality. Credit growth has been strong with continued growth in the retail and SME loan segments. Improvements in digital banking and cost control policy are also positive. Due to these factors, the share price is likely to increase gradually.
ZYDUS LIFE
Last Traded Price @ 930
Support Range @ 909 / 898
Resistance Range @ 939 / 944
The potential for Zydus Lifesciences shares to rise in the coming days is mixed. Demand for the company’s medicines and healthcare products is strong, but competition and regulatory challenges in the global market can sometimes impact profitability. Focus on R&D and a portfolio of new products will be positive for the stock in the long term. Also, exports and international distribution network support the stock.
Ravi Bhatt
SEBI Registered Research Analyst
SEBI Registration Number :- INH000012591
Disclaimer – https://www.capsavaj.com/policies
